Table 1 The features and groupings of 406 patients with DLBCL
Features | Instances (N) |
|---|---|
Age | ≤ 60 (219), > 60 (187) |
Gender | Male (209), Female (197) |
Family history of cancer | No (369), Yes (37) |
Stage | I, II (176), III, IV (230) |
IPI | Low (195), Low-intermediate (79), High-intermediate (83), High (49) |
KPS | ≥ 80 (335), < 80 (71) |
WBC | Low (80), Normal (297), High (29) |
LDH | Normal (312), High (94) |
β2-MG | Normal (296), High (110) |
ESR | Normal (259), High (147) |
Therapy | Chemotherapy alone (347), Chemotherapy and Radiotherapy (59) |
GCB | Yes (243), No (163) |
CD10 | Negative (303), Positive (103) |
Bcl-6 | Negative (59), Positive (347) |
MUM-1 | Negative (222), Positive (184) |
Ki-67 | <  90 (303), ≥ 90 (103) |
Rituximab | Not use (241), Use (165) |